Buy CJC-1295 With DAC Research Peptide
CJC-1295 With DAC is available as a lyophilised powder, independently HPLC and MS-UPLC tested to ≥98% purity.
Buy CJC-1295 With DAC Research Peptide
CJC-1295 With DAC is available as a lyophilised powder, independently HPLC and MS-UPLC tested to ≥98% purity.
HPLC Verified
≥98% purity
Lyophilised
Powder format
Express Shipping
Cold-chain included
COA Available
Every batch
HPLC Verified
≥98% purity
Lyophilised
Powder format
Express Shipping
Cold-chain included
COA Available
Every batch
Same or Next Day Dispatch
Order before 12pm GMT for same-day dispatch; after 12pm ships next business day
Same or Next Day Dispatch
Order before 12pm GMT for same-day dispatch; after 12pm ships next business day
What is CJC-1295 With DAC?
A synthetic analogue of growth hormone-releasing hormone fitted with a Drug Affinity Complex that binds to blood albumin, CJC-1295 with DAC is studied for its extended duration of action. Research focuses on how albumin binding prolongs circulating half-life and sustains activation of the growth hormone-releasing hormone receptor.
- Pharmacokinetic studies in rodents document prolonged circulating peptide concentrations following a single administration.
- In rat pituitary somatotroph preparations, the peptide bound the GHRH receptor and triggered cAMP-mediated signalling.
- Research characterises albumin-peptide dissociation kinetics as the basis for extended receptor occupancy.
- Comparative work contrasts its sustained action with the pulsatile profile of the non-DAC variant.
For research use only. Not intended for human use.
Conjugation of a Drug Affinity Complex to a synthetic GHRH analogue introduced an entirely new pharmacokinetic dimension to growth hormone-releasing hormone receptor research. CJC-1295 With DAC, also designated DAC:GRF (CAS 863288-34-0), is a 30-amino acid peptide with a molecular weight of 3647.28 g/mol. The DAC moiety facilitates covalent binding to circulating albumin. Produced via solid-phase peptide synthesis.
In vitro albumin conjugation assays have investigated the kinetics and efficiency of covalent complex formation under varying physiological conditions. In vivo rodent studies have explored the pharmacokinetic profile of CJC-1295 With DAC relative to unconjugated GHRH analogues, examining plasma half-life extension.
Manufactured in a quality-controlled laboratory to a guaranteed purity of 98% or above. Every batch undergoes independent third-party testing using HPLC and MS-UPLC analysis before dispatch. Vials are vacuum sealed and stored in a temperature-controlled, monitored cold storage system. A batch-specific Certificate of Analysis is available on request.
Sold strictly for in vitro research purposes only. Not for human consumption. Intended for use by qualified researchers in laboratory settings only.
Scientific Review
Scientific review
Dr. Cristina Cosi
Scientific Contributor and Reviewer
Currently under review
View credentials ›What Researchers Say
Sign in to leave a reviewNo reviews yet. Be the first to share your research experience.
Frequently Asked Questions
Related Compounds
GHRP-6
Mol. Wt.
873.01 g/mol
Purity
≥98%
CAS No.
87616-84-0
IGF-1 LR3
Mol. Wt.
9,117.57 g/mol
Purity
≥98%
CAS No.
946870-92-4
Ipamorelin
Mol. Wt.
711.85 g/mol
Purity
≥98%
CAS No.
170851-70-4
Sermorelin
Mol. Wt.
3,357.93 g/mol
Purity
≥98%
CAS No.
86168-78-7
Tesamorelin
Mol. Wt.
5,135.9 g/mol
Purity
≥98%
CAS No.
218949-48-5
MGF (Mechano Growth Factor)
Mol. Wt.
2,867.16 g/mol
Purity
≥98%
CAS No.
162809-23-6
Select Size
Quality Guaranteed
Every batch is HPLC-tested to ≥98% purity. Certificate of Analysis and SDS available on request.